Spring Break
Etching tiny Benny Beaver
While it's not the smallest ever created, newest Beaver logo is smallest created at Oregon State
Daniel Acee
Issue date: 5/2/08 Section: News
Once the etching is complete, the AFM is used to view it by gently tracing the ridges created. It took two days, including development time, to create the beaver logo.
The AMF is run by a series of applications that the team programs to make precise cuts on each of the X, Y and Z dimensions.
In the next few years, Minot can potentially see this technology enhancing the medical field.
He is currently researching how to develop a device that can be used by doctors to detect proteins associated with diseases. [Note: the devices won't go in your body.]
"What we are hoping for is to detect the disease marker proteins at very low levels to stop disease in its early stages," Minot said.
Minot also hopes to combine the field of nanotechnology with pharmaceutical development to get quicker results on whether a certain drug is binding to its target molecule.
"One thing I am hoping for is to get a molecular biology major undergraduate involved in this project; it is a great opportunity to cross physics with molecular biology," Minot said.
Currently between research and teaching classes, Minot is writing proposals to NSF (National Science Foundation) and NIH (National Institutes of Health) hoping to receive funding to increase productivity in his nanotechnology research.
For further information about this project or to contact Minot about joining his team, go to: http://web.science.oregonstate.edu/~minote/.
Daniel Acee, senior reporter
news@dailybarometer.com, 737-2231
The AMF is run by a series of applications that the team programs to make precise cuts on each of the X, Y and Z dimensions.
In the next few years, Minot can potentially see this technology enhancing the medical field.
He is currently researching how to develop a device that can be used by doctors to detect proteins associated with diseases. [Note: the devices won't go in your body.]
"What we are hoping for is to detect the disease marker proteins at very low levels to stop disease in its early stages," Minot said.
Minot also hopes to combine the field of nanotechnology with pharmaceutical development to get quicker results on whether a certain drug is binding to its target molecule.
"One thing I am hoping for is to get a molecular biology major undergraduate involved in this project; it is a great opportunity to cross physics with molecular biology," Minot said.
Currently between research and teaching classes, Minot is writing proposals to NSF (National Science Foundation) and NIH (National Institutes of Health) hoping to receive funding to increase productivity in his nanotechnology research.
For further information about this project or to contact Minot about joining his team, go to: http://web.science.oregonstate.edu/~minote/.
Daniel Acee, senior reporter
news@dailybarometer.com, 737-2231
Note: writers will not reply to comments.
Be the first to comment on this story
Comments by registered users are approved by default.